France Neurostimulation Devices Market Outlook to 2023

  • ID: 4307862
  • Report
  • Region: France
  • 63 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • St. Jude Medical LLC
  • MORE
France Neurostimulation Devices Market Outlook to 2023

Summary

The new report, "France Neurostimulation Devices Market Outlook to 2023", provides key market data on the France Neurostimulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neurostimulation Devices market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the France Neurostimulation Devices market.
- Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • St. Jude Medical LLC
  • MORE
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurostimulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurostimulation Devices Market, France
3.1 Neurostimulation Devices Market, France, Revenue ($m), 2009-2016
3.2 Neurostimulation Devices Market, France, Revenue ($m), 2016-2023
3.3 Neurostimulation Devices Market, France, Volume (Units), 2009-2016
3.4 Neurostimulation Devices Market, France, Volume (Units), 2016-2023
3.5 Neurostimulation Devices Market, France, Average Price ($), 2009-2023
3.6 Neurostimulation Devices Market, France, Distribution Share by Revenue ($m), 2015-2016
3.7 Neurostimulation Devices Market, France, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in France, Neurostimulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 St. Jude Medical LLC
4.2.1 Company Overview
4.3 LivaNova PLC
4.3.1 Company Overview
4.4 Boston Scientific Corp
4.4.1 Company Overview
5 Neurostimulation Devices Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
6.1.2 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
6.1.3 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
6.1.4 Mar 02, 2017: Sanofi’s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
6.1.5 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
6.1.6 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
6.1.7 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare
6.1.8 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation
6.1.9 Sep 06, 2016: Sanofi Board Of Directors Provides Update
6.1.10 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
6.2 Financial Announcements
6.2.1 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
6.2.2 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
6.2.3 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results
6.2.4 Jul 29, 2016: Sanofi Announces Q2 2016 Results
6.2.5 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi
6.3 Government and Public Interest
6.3.1 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
6.3.2 Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
6.4 Other Significant Developments
6.4.1 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
6.5 Strategy And Business Planning
6.5.1 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Company Share Analysis
7.1.5 Distribution Share Analysis
7.1.6 Benchmarking
7.2 Consulting
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Neurostimulation Devices Market, France, Volume (Units), Historic, 2009-2016
Table 4: Neurostimulation Devices Market, France, Volume (Units), Forecast, 2016-2023
Table 5: Neurostimulation Devices Market, France, Average Price ($), Historic, 2009-2016
Table 6: Neurostimulation Devices Market, France, Average Price ($), Forecast, 2016-2023
Table 7: Neurostimulation Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 8: Neurostimulation Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Neurostimulation Devices Market Pipeline Products

1.2 List of Figures
Figure 1: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Neurostimulation Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Neurostimulation Devices Market, France, Volume (Units), Historic, 2009-2016
Figure 4: Neurostimulation Devices Market, France, Volume (Units), Forecast, 2016-2023
Figure 5: Neurostimulation Devices Market, France, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic Plc
  • St. Jude Medical LLC
  • LivaNova PLC
  • Boston Scientific Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll